Telomir Pharmaceuticals, Inc. (TELO) Ownership - Who Owns Telomir Pharmaceuticals, Inc.?
Telomir Pharmaceuticals, Inc. (TELO) Ownership Overview
- 9.94% Insiders
- 2.61% Mutual Funds
- 0.04% Other Institutional Investors
- 2.33% ETFs
- 85.08% Public Companies and Individual Investors
The ownership structure of Telomir Pharmaceuticals, Inc. (TELO) stock is a mix of institutional, retail, and individual investors. Approximately 4.98% of the company’s stock is owned by Institutional Investors, 9.94% is owned by Insiders, and 85.08% is owned by Public Companies and Individual Investors.
The ownership structure of Telomir Pharmaceuticals, Inc. (TELO) stock is a mix of institutional, retail, and individual investors. Approximately 4.98% of the company’s stock is owned by Institutional Investors, 9.94% is owned by Insiders, and 85.08% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Aminov Erez | 7,319,710 | Insider | 9.94% | 6,843,929 |
| Vanguard | 1,593,798 | Institution | 2.16% | 1,490,201 |
| Vanguard Index Funds | 1,593,798 | Institution | 2.16% | 1,490,201 |
| Fidelity Concord Street Trust | 307,089 | Institution | 0.42% | 287,128 |
| Ishares | 119,523 | Institution | 0.16% | 111,754 |
| Donald R. Jowdy | 51,194 | Institution | 0.07% | 47,866 |
| Vanguard Valley Forge Funds | 19,841 | Institution | 0.03% | 18,551 |
| Profunds | 69 | Institution | <0.01% | 65 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 1,593,798 | Institution | 2.16% | 1,490,201 |
| Fidelity Concord Street Trust | 307,089 | Institution | 0.42% | 287,128 |
| Vanguard Valley Forge Funds | 19,841 | Institution | 0.03% | 18,551 |
| Profunds | 69 | Institution | <0.01% | 65 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VTI ETF | 1,121,175 | Institution | 1.52% | 1,345,410 |
| Vanguard, VXF ETF | 472,623 | Institution | 0.64% | 567,148 |
| iShares, IWC ETF | 119,523 | Institution | 0.16% | 115,244 |
FAQ
Who Owns Telomir Pharmaceuticals, Inc. (TELO)?
According to the latest TipRanks data, approximately 4.98% of the company's stock is held by institutional investors, 9.94% is held by insiders, and 85.08% is held by public companies and individual investors.
What percentage of Telomir Pharmaceuticals, Inc. (TELO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.98% of Telomir Pharmaceuticals, Inc. (TELO) stock is held by institutional investors: 2.61% by mutual funds, 2.33% by ETFs and 0.04% by other institutional investors.
What percentage of Telomir Pharmaceuticals, Inc. (TELO) stock is held by retail investors?
According to the latest TipRanks data, approximately 85.08% of Telomir Pharmaceuticals, Inc. (TELO) stock is held by public companies and individual investors.
Who owns the most shares of Telomir Pharmaceuticals, Inc. (TELO)?
Aminov Erez owns the most shares of Telomir Pharmaceuticals, Inc. (TELO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.